Watch · 52/100 · high confidence

VALLEY NATIONAL BANCORP (VLY) — Council Assessment

🟡 WATCH · Score 52/100 · high confidence

A genuinely improving regional bank turnaround that has already re-rated 75% to fair value at ~1.0x book — good execution, no margin of safety.

As of 2026-06-27. 13 lenses weighed in, 5 abstained. Sources: 6 filings, 15 news, 15 discussion, 1 earnings_call.

360 narrative — news & sentiment digest

Valley National Bancorp (VLY) — Investment Brief

Management Commentary (Q4 2025 Earnings Call)

Earnings & Profitability

Record Q4 2025 net income: $195M ($0.33 diluted EPS reported; $0.31 adjusted). FY2025: $598M net income ($585M adjusted).
Adjusted ROA of 1.14%—highest since Q4 2022. Management framed 2025 as a "fortified balance sheet" year, exceeding profitability targets.

Deposit & Funding Strategy (Core Achievement)

Core deposit growth of ~$4B (9% YoY)—highlighted as "one of our most significant achievements." Q4 alone added $1.5B core deposits.
Noninterest-bearing deposit growth >15% annualized in Q4, though management cautioned late-quarter spike will moderate.
Deposit cost beta: 55% in Q4 (vs. 50% modeled long-term). Paid down $500M higher-cost broker deposits using core deposit inflows.
Total deposit costs fell 24bp sequentially; new originations blended at 217bp (down from 291bp in Q3).

Loan Growth & Pipeline

Total loans grew $800M (7% annualized). First sequential CRE growth since Q2 2024, primarily owner-occupied.
Commercial real estate originations accelerating; continuing strategic runoff of non-relationship CRE.
Loan pipeline exceptionally strong: up >$1B (~70% YoY) from year-ago, with $600M increase in C&I and $700M in CRE. Recent hires in NJ, CA, FL already generating activity.
2026 loan-growth guidance: mid-single-digit overall; ~10% C&I, low-single-digit CRE, mid-single-digit consumer/residential.

Net Interest Margin & Revenue

NIM expanded to 3.17% (beat 3.1% Q4 target). Q4 NII up 4% QoQ, 10% YoY.
2026 guidance: 15–20bp additional margin expansion (Q4 2025 to Q4 2026), with tailwinds on both sides: repricing customer deposits lower, $600M FHLB advances (~4.7%) maturing, $1.8B fixed-rate loans (~4.7%) repricing 150–200bp higher.
Management assumes two rate cuts in 2026; remains "generally neutral to the front end of the yield curve."
Margin expected to dip slightly in Q1 2026 (from 3.17%) due to lower day count, elevated noninterest bearing deposits at year-end, and seasonal deposit outflows—then recover through the year toward "mid-330s" by Q4.

Fee Income

Q4 benefited from "abnormally high" swap fees and FinTech equity valuation gains (episodic, not recurring).
Core fee income guidance for 2026: high single-digit growth; targeting mid-to-high $60M per quarter baseline.

Credit & Reserves

Criticized & classified loans declined $350M (8%) in Q4; total nonaccrual loans essentially flat.
Net charge-offs: 18bp average loans in Q4; FY2025 24bp vs. 40bp in 2024 (improvement).
One C&I credit moved to nonaccrual (10+ years in portfolio, syndicated, modified, structural payments support).
Allowance coverage ratio stable; expect further normalization in credit costs in 2026.
2026 provision guidance: ~$100M (implying credit cost improvement/stability).

Capital & Shareholder Returns

CET1 to remain in 10.5%–11% target range. Q4 returned $109M to shareholders ($188M quarterly net income common)—38bp CET1 generation, ~half retained for loan growth, half returned.
2026 capital generation: CET1 on gross basis up 130–140bp; ~50bp to support loan growth, ~50bp dividends, 30–40bp for buybacks (~$150–200M stock repurchases expected; Q4 pace ~$48M).
Share repurchases: $60M+ in 2025; 6M+ shares bought back (4M in Q4 alone).

Expenses & Efficiency

FY2025 adjusted expenses grew 2.6% (well below 9% revenue growth). Q4 elevated by new branding campaign (~half of expense growth) and performance accrual for operational milestones.
2026 guidance: low single-digit expense growth as talent/tech/branding investments offset by efficiency gains elsewhere.
Efficiency ratio expected to trend toward 50% throughout 2026.

Strategic Priorities & Talent

Continued geographic diversification (recent success in Chicago, LA post-Leumi; expanding Philadelphia; exploring adjacent markets).
Heavy investment in commercial banker recruiting; management cites "unique value proposition" (size, relationship focus, capital markets, treasury platform, data/AI).
New hires (e.g., Gina Martocci, Patrick Smith—small business/branding lead) already contributing to loan/deposit pipeline.
Branding campaign ("That's How") to complement small-business and consumer growth, funding talent investments with operational offsets (AI, cost of service).

M&A Perspective

Management explicitly stated no current M&A plans; focus on organic execution is strong. M&A would need to (1) prioritize current shareholders, (2) avoid dilution, (3) align with strategic objectives (deposit growth, loan pipeline, geographic expansion). "There's an unbelievable organic story unraveling here."

Analyst Q&A Highlights

On rate scenarios: Neutral assumption, but if rates fall less than two cuts, "slight, very slight headwind" to NII offset by higher 2–5–10yr yields. Management has "outperformed beta assumptions" on prior fed cuts.
On deposit betas: Conservatively modeling 50% total betas FY2026 (actual FY2025: 60%); NIB guidance 5% growth, M&MM ~7%, CDs modest.
On CRE concentration: Will "modestly improve" despite $1B net CRE growth, as C&I & consumer growth outpace.
On expense discipline: Management noted 280+ employee growth (from 3,351 to 3,634) while tripling balance sheet ($20B→$60B), demonstrating operating leverage; AI/ML efforts ongoing.

Recent Developments

Q4 2025 earnings (Jan 31, 2026): Record profitability; deposit momentum accelerating; loan pipeline inflection.
Analyst target-price revisions (Mar–Jun 2026): Street raising price targets toward $16 (per Yahoo Finance headline); stock up ~23% YTD 2026, up 75% over one year (per simplywall.st).
Stock performance: 52-week high $14.12 (Jun 9, 2026); trading mid-$13–$14 range in late Jun 2026.
Institutional buying noted; coverage expansion and analyst upgrade sentiment evident.

Bull Narrative

Deposit inflection achieved: $4B core-deposit growth in 2025 proves repricing/relationship banking model working. Noninterest deposits surging (>15% annualized Q4); funding mix improving durably.
Margin expansion tailwinds intact: 15–20bp NIM expansion 2026 (via repricing, FHLB/fixed-rate loan maturation) with limited rate-cut sensitivity. Management outperforming prior beta expectations.
Loan growth accelerating: $1B+ pipeline growth YoY, with C&I and CRE originations ramping. First CRE sequential growth in 18mo signals discipline is paying off. 2026 guidance for mid-single-digit growth with deposit growth outpacing loans → further LTD reduction.
Credit normalizing: Criticized/classified loans declining; charge-offs falling (24bp → likely lower in 2026). One large C&I move to nonaccrual is isolated/manageable; no systemic stress.
Operating leverage maturing: Expense growth (2.6%) far below revenue growth (9%); efficiency ratio compressing toward 50%. New banker hires and branding now flowing through P&L. AI/data investments enabling productivity.
ROE inflection story: Adjusted ROE 13%+ in Q4; management on track for 15% by late 2027/early 2028. Further upside if margin expansion and credit stabilization sustain.
Capital deployment balanced: ~$150–200M annual buybacks sustainable within target CET1 range (10.5%–11%); dividends stable; loan growth funded organically.
Analyst re-rating: Street upgrading price targets to $16+, citing improving asset quality, deposit diversification, and operating leverage.

Bear Narrative

Execution risk on deposit growth: Q4 noninterest-bearing surge likely unsustainable (management flagged moderation in Q1 2026). If NIB growth falls short of 5% guidance, NIM benefit erodes.
Margin expansion assumptions aggressive: 15–20bp expansion assumes (a) two rate cuts in 2026, (b) continued repricing discipline, (c) beta outperformance. If rates higher or competition intensifies on deposits, upside diminishes.
Loan growth guidance conservative or difficult to achieve: $1B net CRE guidance includes $500M runoff (non-relationship portfolio). Market competition intensifying (management acknowledges "minor compression"); spreads "fairly consistent" but "conservatively assuming modest compression." If CRE weakness persists or C&I originations slow, growth target misses.
Cost of deposit originations rising: New deposit rates 217bp (Q4) competitive; if competitive pressure mounts, origination costs rise, eroding deposit margin benefit.
Fee income lumpiness: Q4 benefited from episodic swap fees and FinTech gains; core fee guidance (high single-digit growth) muted vs. loan/deposit momentum. Revenue diversification still limited.
Expense creep risk: "Low single-digit" expense guidance assumes banker hires are immediately productive (no ramp). Branding investment ($7–8M Q4 hit) may not generate proportional ROI; AI initiatives still maturing.
Valuation extended: Stock up 23% YTD 2026, 75% one-year; street target $16 implies limited upside from current $13–14 range. Risk/reward asymmetric if growth or margin guidance moderates.
Macro sensitivity: If 2026 rate cuts don't materialize or economy weakens, loan growth and credit quality assumptions break. Regional bank sector still grappling with deposit flight/funding pressures post-2023 crisis.

Retail Sentiment

Overall: Bullish/mixed conviction

Bull camp (dominant): Highlights strong earnings, deposit growth, "should be $20," acquisition candidacy. Users cite strong trajectory and undervaluation relative to peer banks.
Tactical traders: Eyeing options (Jan 2027 $15 calls at 55–68¢, targeting 60% ROI), suggesting near-term consolidation before re-rating.
Caution notes: Some flagging "fakey breakouts" in regional-bank group; want to see reclaim of key pivots before re-engagement. One user critical of "high salaries" dampening earnings upside.
Acquisition chatter: Multiple users citing M&A as likely catalyst ("top of my list for eventually getting bought out").

Conviction: Moderate to high; sentiment tilted bullish, but mixed on near-term technicals. Retail sees multi-year value thesis but cognizant of recent run-up.

Caveats

Guidance conservatism unclear: Management claims "exceptional" pipelines and "very strong" momentum, yet guidance is mid-single-digit loan growth (5% midpoint). Unclear if guidance is truly conservative or if execution risk is embedded.
Analyst coverage breadth: Limited public intel on sell-side consensus; only three analyst names mentioned (Jefferies, B. Riley, JPMorgan in Q&A). Street targets ($16) cited in headlines but not independently validated here.
First-quarter seasonality disclosure:

Bull case

The operational inflection is real and multi-lens confirmed: core deposits grew ~$4B (9% YoY), NIM expanded to 3.17% with 15-20bp further guided, charge-offs fell from 40bp to 24bp, criticized/classified loans dropped $350M, and efficiency is compressing toward 50%. Adjusted ROA hit 1.14% (best since Q4 2022) and Q1 2026 EPS was up 55% YoY. Management is candid, capital-disciplined (CET1 10.5-11%, $150-200M buybacks, no dilutive M&A). The excess-return/DDM model (Valuation Referee) puts intrinsic value at ~$18-19 if 13% ROE is achieved sustainably, ~25% upside. The AI/disruption referee scores it highest (72) — a chartered relationship bank is structurally AI-resilient. Lynch notes an attractive ~0.73 PEG. If management delivers the glide path to 13-15% ROE, 1.0x book is cheap.

Bear case

At $14.72 (52-week high, up ~75%) the stock trades at ~1.01x book while trailing ROE is only 7.66% — below the ~10.5% cost of equity, meaning the bank is currently value-destructive on incremental equity. The market is paying full price for a forward ROE improvement that requires simultaneous execution: two rate cuts, NIM expansion, deposit-beta discipline, and benign CRE credit. Every value lens (Graham, Klarman, Schloss, Munger, Buffett) flags the absence of margin of safety — the conservative bear case (ROE stays 7-9%) implies $10-12, 20-30% downside. Street targets of $16 imply only ~9% upside: unfavorable asymmetry. Book value is inflated by Leumi-era goodwill/intangibles, CRE concentration remains a debt-cycle risk, and the Q4 NIB deposit surge and episodic swap/FinTech fee gains flatter recent results.

Dissent — where the council disagrees

Sharp split between the AI/disruption referee (PASS 72 — structurally AI-resilient charter, cost tailwind) and every value/quality lens (Watch 45-55). The Valuation Referee is decisive: at 7.66% ROE vs ~10.5% Ke, VLY should trade BELOW book yet trades AT book — the price already embeds forward ROE improvement, so there is no margin of safety for a long-term owner. The Forensic Short-Seller flags a real quality-of-earnings issue: net income ($598M) exceeds operating cash flow ($344M) by ~74%, and management itself called the Q4 NIB deposit surge unsustainable. Druckenmiller's point cuts hardest for entry timing — the asymmetry is gone after the tape already moved 75% and consensus caught up to $16. Note the qualified/deep-value quality masters (Akre, Fisher, Greenblatt, Greenwald, Terry Smith) ABSTAINED entirely — banking is outside their circle — so this decision rests almost entirely on the risk, value, and referee lenses, all of which land at Watch.

Key risks

CRE concentration in NJ/NY/FL amid cap-rate normalization — the historical epicenter of regional-bank distress; vintage 2026 CRE growth could seed 2027-28 losses
Rate-path dependency: the entire NIM-expansion thesis assumes two 2026 Fed cuts plus deposit-beta discipline; a hawkish surprise breaks the bull case
ROE stuck at 7-9% (below cost of equity) would re-rate the stock toward 0.8-0.85x book (~$11-12)
Earnings quality: net income exceeds operating cash flow by ~74%; Q4 fees inflated by episodic swap and FinTech gains; book inflated by Leumi goodwill/intangibles
Thin margin of safety at 52-week high after a 75% rally — any guidance miss (NIM below ~3.30%, provision above $100M) triggers an air-pocket re-rating
Stale balance-sheet data in fact base (2018-era cash/LT debt) reduces confidence in the funding-structure assessment

Catalysts

Q1-Q2 2026 NIM trajectory recovering toward mid-330s and reaching 3.30%+ by Q3 confirms the expansion thesis
Sustained core deposit growth (>5% NIB) and continued deposit-cost declines proving funding-cost moat
Delivery of 13%+ adjusted ROE toward the 15% 2027-28 target — re-rating catalyst to 1.2-1.4x book
FHLB advances (~$600M at 4.7%) and $1.8B fixed-rate loans repricing higher through 2026
$150-200M buybacks executed below/near book value accreting per-share value
Fed cuts materializing as assumed, driving deposit repricing lower

DCF valuation

Not applicable: FCF-based DCF is not appropriate for Banking — banks/insurers are valued on P/B and ROE, REITs on P/FFO and cap rates.

Short-sell evaluation

🚫 AVOID SHORTING

VLY is a poor short despite full valuation. The classic short triggers — fraud, secular decline, extreme overvaluation, distress — are absent. At ~1.01x book and 13x earnings the stock is fair-to-full, not bubble-priced, so there's no valuation air to short into. Meanwhile fundamentals are demonstrably improving (NIM, deposits, charge-offs, efficiency all moving the right way) with strong positive momentum, active buybacks, dividends, and a credible management team — a lethal combination against a short. The only real short vectors are the ~74% net-income-vs-CFO gap, CRE overhang, and rate-path dependency, but none are acute enough to overcome the momentum, buyback support, and asymmetric unlimited-downside risk of shorting a re-rating turnaround. A specialist might play a specific negative catalyst (NIM miss, CRE credit event), but that is a tactical trade, not a durable short.

Pros (the short could work)

Trades at ~1.0x book with trailing ROE (7.66%) below cost of equity (~10.5%) — arguably worth below book if ROE doesn't inflect; bear-case fair value ~$10-12
Net income exceeds operating cash flow by ~74%; FCF well below net income — quality-of-earnings flag
Air-pocket risk: at 52-week high after 75% rally with consensus $16 target, any NIM/provision miss triggers rapid downward re-rating
CRE concentration resuming growth after runoff — potential for credit deterioration exceeding the ~$100M provision guide
Thesis leans on episodic Q4 fee gains (swap, FinTech) and an NIB deposit surge management itself called unsustainable

Cons (what kills the short)

Fundamentals improving across the board (NIM, deposits, credit, efficiency) — shorting an accelerating turnaround is dangerous
Strong positive momentum and analyst target raises; stock at 52-week high with institutional buying — squeeze/pain risk
Valuation is fair, not bubble — 1.0x book / 13x P/E offers little room for a valuation-driven short to work
Active $150-200M buybacks plus dividends and ~130-140bp annual CET1 generation provide a support bid
Credible, candid management with no dilutive M&A; readable balance sheet — no governance/fraud angle to exploit
Unlimited downside asymmetry against a re-rating story; borrow cost and squeeze risk outweigh a thin overvaluation edge

Council scorecard

Lens	School	Stance	Score	Conf
AI & Disruption Referee (Christensen-style)	referee	🟢 pass	72	medium
Howard Marks	risk	🟡 watch	55	medium
Ray Dalio	risk	🟡 watch	52	medium
Valuation Referee (Damodaran-style)	referee	🟡 watch	52	medium
Stanley Druckenmiller	risk	🟡 watch	52	medium
Benjamin Graham	value	🟡 watch	52	medium
Peter Lynch	growth	🟡 watch	52	medium
Michael Mauboussin	quality	🟡 watch	52	medium
Warren Buffett	quality	🟡 watch	48	medium
Seth Klarman	value	🟡 watch	48	medium
Walter Schloss	value	🟡 watch	48	medium
Forensic Short-Seller (Chanos/Einhorn-style)	referee	🟡 watch	48	medium
Charlie Munger	quality	🟡 watch	45	medium
Chuck Akre	quality	⚪ abstain	—	high
Philip Fisher	growth	⚪ abstain	—	high
Joel Greenblatt	value	⚪ abstain	—	high
Bruce Greenwald	value	⚪ abstain	—	high
Terry Smith (Fundsmith)	quality	⚪ abstain	—	high

Member reasoning

AI & Disruption Referee (Christensen-style) — 🟢 pass · 72/100 · medium confidence

Valley National Bancorp (VLY) is a traditional regional bank whose core business — deposit-taking, commercial lending, and relationship banking — is structurally among the most AI-resilient financial services models over a 3-10 year horizon. The Christensen disintermediation test asks: can AI do cheaper what VLY does, removing the need for VLY? For a regulated deposit-taking institution, the answer is largely no, because the value delivered is not primarily matching/aggregation/optimization — it is regulated credit extension, relationship trust, deposit insurance backing, and compliance infrastructure. No AI model eliminates the need for a chartered bank. That said, AI poses real but bounded threats on the margin, and management's posture on AI is directionally correct. The net verdict is cautiously positive: AI is more tailwind than threat here, but not a compounding moat builder either. The specific job VLY does: it originates commercial loans (C&I, CRE) through relationship bankers, funds them with retail/commercial deposits, and earns a spread. The AI threat on loan origination is real but modest — AI can accelerate underwriting, improve credit scoring, and reduce headcount in back-office processing, but the relationship-driven commercial lending model (where banker relationships drive deal flow, and borrower trust/local knowledge are real differentiators) is not easily automated. The deposit-gathering function similarly depends on trust, FDIC backing, and local presence — not replicable by an LLM. Disintermediation risk is low: unlike a marketplace or aggregator, VLY is not a toll-taker between two parties that AI could route around. The charter, balance sheet, and regulatory infrastructure are genuine scarce assets. On the cost-AI tailwind side, management explicitly references AI/ML investments for operational efficiency — the Q4 2025 narrative notes 'AI, cost of service' as efficiency offsets enabling hiring, and management cited tripling the balance sheet with modest headcount growth (3,351 to 3,634 employees) as evidence of operating leverage. The 'That's How' branding campaign and digital tools for small business acquisition suggest awareness of tech-enabled distribution. Hyperscaler threat is present but indirect: fintech lenders (e.g., Upstart, Blend) and embedded finance platforms pose competition for consumer/small-business origination, but VLY's focus on middle-market C&I and CRE lending is less exposed to fintech disruption than consumer lending. The CRE/C&I relationship model, where deal complexity and borrower relationships matter, is stickier. Fee income (swap fees, FinTech equity stakes) is episodic and not a major AI exposure vector. Pricing power: bank NIM is structurally determined by rates and deposit competition, not AI-driven commoditization. The biggest AI-adjacent risk is deposit competition — neobanks and AI-powered fintech deposit platforms can gather deposits cheaply, pressuring VLY's cost of funds. VLY's 55% deposit beta and $4B core deposit growth in 2025 suggest this has been manageable, but ongoing pressure is real. Management's AI posture: they mention data/AI as a competitive differentiator in talent recruiting and reference AI/ML for cost efficiency, but the earnings call narrative does not deeply engage with the displacement risk to their model — which is appropriate for a bank (the risk is genuinely low) but also shows limited strategic depth on the topic. Falsifiable call: confirmation of AI threat would be NIM compression from deposit competition with fintech platforms, rising loan origination costs from AI-native competitors underpricing VLY on small business loans, or meaningful C&I share loss to embedded finance. Disconfirmation would be continued deposit growth outpacing guidance, stable or expanding loan spreads, and AI-driven efficiency ratio improvement below 50%.

Key points

Chartered bank with regulated balance sheet is not disintermediated by AI — the core function (credit extension, deposit insurance, compliance) requires a charter and capital, not just a model
Relationship-driven commercial lending (C&I, CRE) resists AI commoditization more than consumer lending; deal complexity and local knowledge are real moat contributors
AI is a genuine cost tailwind: management cites AI/ML for operational efficiency, consistent with tripling assets with modest headcount growth — this supports the efficiency ratio trajectory toward 50%
Deposit-gathering risk from fintech/neobank competition is the primary AI-adjacent threat, but VLY's $4B core deposit growth in 2025 suggests the model is competitive
Hyperscaler risk is indirect — no Google or Microsoft product replaces a commercial bank charter or relationship banker for middle-market borrowers
Management acknowledges AI as operational tool; appropriate for this business type where displacement risk is genuinely low rather than denial of a real threat

Red flags

Fintech deposit platforms (high-yield savings, neobanks) powered by AI-driven customer acquisition could pressure VLY's deposit costs over a 3-7 year horizon — early signs visible in competitive deposit pricing (new originations at 217bp)
Small business and consumer lending segments are more exposed to AI-native origination platforms (Upstart-style models) that could erode loan growth in those sub-segments
Management's AI commentary is thin — references to 'data/AI' and 'AI, cost of service' lack specificity; no concrete disclosure of AI investment spend or measurable productivity gains, creating uncertainty about whether efficiency gains are durable or aspirational
Fee income diversification into FinTech equity stakes introduces indirect exposure to AI disruption within those portfolio companies — not quantified in available filings

Howard Marks — 🟡 watch · 55/100 · medium confidence

Valley National Bancorp presents a genuinely interesting risk/reward calculation but does not yet clear a high bar for a compelling Marks-style entry. The core question is: what is priced in, and is the current price a bargain relative to conservatively estimated value? The stock has rallied ~75% over one year and ~23% YTD 2026, reaching its 52-week high. At ~1.01x book, 13x trailing P/E, and with a P/B approaching tangible-book parity, the 'deep discount to value' that characterizes a classic Marks buy is absent. The pendulum has swung from fear (sub-$9 in the 52-week low period) toward optimism — the market has already re-rated much of the improvement in deposit costs, NIM expansion, and credit quality. That said, VLY is not in the 'fully priced perfection' danger zone either. ROE at 7.66% trailing (adjusted ~13% in Q4 2025) still lags cost of equity for most regional banks, meaning P/B at 1.01x is not yet euphoric. Street consensus targets $16 (vs. $14.72 current), implying ~9% upside — modest, but the real call is whether continued NIM expansion (15–20bp guided for 2026) and ROE improvement toward 15% by 2027–28 will drive a re-rating to 1.2–1.4x book, which would place intrinsic value closer to $17–22. That is the bull case the crowd is beginning to price in. On capital structure: for a $64B asset bank, leverage is inherently high (total liabilities $56.3B vs. equity $7.8B — ~7.2x leverage), but CET1 at 10.5–11% is adequate and management is generating ~130–140bp CET1 annually. Interest coverage is not separately disclosed but NIM at 3.17% on $64B assets generates well over $2B NII against manageable funding costs. The 2026 provision guidance of ~$100M (vs. $598M net income) implies 17bp of assets — manageable. Deposit beta discipline (55% actual vs. 50% modeled) and the $4B core deposit growth in 2025 suggest the funding base is more stable than feared in 2023. Where I remain cautious: (1) sentiment has shifted from revulsion to optimism — retail chatter is bullish, analysts are raising targets, stock is at 52-week high; the easy contrarian trade has been made; (2) the margin of safety vs. a bear scenario (slower loan growth, rate cuts don't materialize, deposit competition intensifies, CRE stress re-emerges) is thin at current prices — the stock already prices in execution of the 2026 guidance with limited cushion for disappointment; (3) fee income is lumpy and episodic (swap fees, FinTech gains), making core earnings quality somewhat uncertain; (4) the one C&I nonaccrual credit and continued CRE runoff are manageable individually but signal ongoing credit vigilance is required. This is not a situation of forced selling, capitulation, or deep discount to liquidation value — it is a turnaround that has partially re-rated. A Marks entry would have been far more attractive at $8–10 (when pessimism was in the price). At $14.72, the risk/reward is balanced but not asymmetrically favorable. Watch for a pullback toward $12–13 (0.85–0.9x book) or evidence that the Q1 2026 NIM dip was worse than guided — either would restore a more interesting margin of safety.

Key points

Stock has already rallied ~75% in one year — the 'fear trade' has been made; sentiment is now bullish/mixed optimism, not panic
P/B at 1.01x is not cheap but not euphoric for a bank with ROE improving from ~8% toward 13%+ adjusted; intrinsic value closer to $17–20 if ROE sustains at 13–15%
Capital structure is bank-typical leverage (~7x assets/equity) but CET1 10.5–11% is sound and being generated organically at 130–140bp annually
Q4 2025 record net income $195M, adjusted ROA 1.14% — genuine operational improvement, not financial engineering
$4B core deposit growth in 2025 and deposit cost beta discipline are real, durable balance-sheet improvements reducing funding fragility
2026 provision guidance $100M vs. $598M net income — credit stress appears contained; criticized/classified loans declining
No M&A overhang; management explicitly rejecting dilutive deals — capital discipline is credible
Street target $16 implies only ~9% upside from $14.72 — embedded expectations have risen significantly, limiting asymmetry

Red flags

Optimism is now being priced in — stock at 52-week high, retail chatter bullish, analysts raising targets; the contrarian window (sub-$10) has closed
Margin of safety is thin: at 1.01x book, any NIM disappointment, deposit competition spike, or CRE credit event would compress valuation back toward 0.8–0.85x book ($11–12)
Fee income quality is uncertain — Q4 benefited from episodic swap fees and FinTech gains; core run-rate lower than reported
Q1 2026 NIM guided to dip sequentially before recovering — execution of the 2026 margin expansion story requires multiple favorable developments (rate cuts, repricing, FHLB maturities) all materializing
CRE concentration remains elevated even as it 'modestly improves'; commercial real estate stress in 2026 macro scenario is a real tail risk
Bank-sector sentiment broadly improving — this is late in the regional-bank recovery cycle relative to 2023 stress lows; chasing here has late-cycle characteristics
Noninterest-bearing deposit surge in Q4 2025 flagged by management as likely to moderate — if NIB mix deteriorates faster than guided, NIM tailwind shrinks

Ray Dalio — 🟡 watch · 52/100 · medium confidence

Valley National Bancorp is a classic macro-exposed, rate-sensitive regional bank — precisely the type of holding my framework is designed to stress-test. Banks ARE the debt cycle; they sit at the intersection of credit creation, rate regimes, and balance-sheet leverage. VLY is not abstain territory. The bank has made genuine progress: NIM expanded to 3.17%, core deposits grew ~$4B (9% YoY), criticized/classified loans declined $350M in Q4 2025, CET1 is tracking 10.5–11%, and the efficiency ratio is compressing toward 50%. Adjusted ROA hit 1.14% — respectable for a mid-size regional. However, from a regime-robustness and debt-cycle perspective, VLY carries meaningful vulnerabilities. First, single-regime dependence: the entire 2026 earnings thesis (15–20bp NIM expansion, mid-single-digit loan growth, ~$100M provision) assumes a benign landing — two rate cuts, no credit deterioration, no deposit outflows. In stagflation (rising rates + slowing growth), loan demand weakens while deposit competition intensifies, NIM compresses, and credit losses spike simultaneously. In a deflationary bust (deleveraging), loan growth stalls, CRE marks deteriorate, and the bank's $64B asset base faces impairment risk. VLY only clearly wins in the falling-rates + stable-growth or rising-rates + strong-growth box, and even then its beta is meaningful. Second, CRE concentration is a debt-cycle red flag. Though management is running off non-relationship CRE, the portfolio still carries substantial CRE exposure in a market where office and multifamily face structural headwinds and cap-rate normalization has pressured collateral values. A credit contraction in CRE — historically the epicenter of regional bank distress — would test this balance sheet. Third, funding structure: $1.654B long-term debt (per 2018 filing data — stale; actual current structure unclear from filings provided), plus FHLB advances (~$600M at 4.7% maturing in 2026, which is a tailwind but also reflects prior reliance on wholesale funding). The bank still has broker deposit exposure ($500M paid down in Q4 but residual balance unknown). Operating cash flow of $344M vs. net income of $598M suggests meaningful non-cash adjustments — requires deeper scrutiny. Fourth, geographic concentration: primarily NJ/NY/FL commercial real estate and C&I — all U.S. dollar, correlated to U.S. credit cycle, no international diversification. Fifth, valuation: stock up 75% one-year, trading at ~1.01x book with ROE of only 7.66% (trailing; adjusted ROE ~13% per management). P/B near book is not expensive, and P/E of 13x is modest, BUT the current price is at its 52-week high and already reflects much of the 2026 margin expansion story. On the positive side: P/B near 1.0x provides some margin of safety in a stress scenario; the deposit franchise is genuinely improving; expense discipline is real; and CET1 at ~10.5–11% provides a buffer. The bank is not over-leveraged in the traditional sense — equity/assets ~12.2% (bank leverage). However, for a Dalio framework, the regime-dependence on the soft-landing, the CRE overhang, the wholesale funding history, and the absence of any inflation pass-through mechanism (banks don't have pricing power over credit demand) collectively limit the score. This is a watch — not an avoid — because credit quality is genuinely improving, the deposit franchise story has legs, and valuation is not egregious. But it is not a pass because it fails the regime-robustness test and sits in the late stage of a credit cycle where CRE stress has not fully resolved.

Key points

NIM expanded to 3.17% with 15-20bp additional expansion guided for 2026 — a genuine tailwind in the current rate environment
Core deposit growth of $4B (9% YoY) with NIB surge reduces reliance on wholesale funding — balance sheet improvement is real
CET1 tracking 10.5-11% provides regulatory buffer; adjusted ROA 1.14% is the best since 2022, confirming operational recovery
P/B ~1.01x and P/E ~13x offer modest margin of safety relative to book value — not a bubble valuation
Criticized/classified loans down $350M in Q4; net charge-offs improved from 40bp (2024) to 24bp (2025) — credit normalization underway
$150-200M annual buybacks within capital generation capacity — disciplined return of capital
Efficiency ratio compressing toward 50% demonstrates operating leverage on an essentially fixed cost base

Red flags

Single-regime dependence: the entire 2026 bull case requires benign macro — soft landing, two rate cuts, stable CRE collateral. Stagflation or deflationary deleveraging breaks the thesis simultaneously on NIM, loan demand, and credit quality
CRE concentration is the key debt-cycle vulnerability; cap-rate normalization has already stressed CRE collateral values nationally; VLY's runoff strategy is right but slow — residual exposure is large relative to equity
Funding structure uncertainty: 2018-era debt/cash data in the fact base is stale; wholesale funding (FHLB, broker deposits) history signals prior balance-sheet fragility; residual broker deposit balance not disclosed in summary
ROE of 7.66% (GAAP trailing) is below cost of equity for most rate environments — value creation only materializes if management's 13%+ adjusted ROE trajectory sustains, which requires the benign macro assumption
Stock at 52-week high after 75% one-year rally — current price already embeds significant portion of 2026 NIM expansion and credit improvement, leaving limited margin of safety for a regime shift
Geographic concentration 100% U.S., primarily NJ/NY/FL CRE and C&I — maximum correlation to U.S. credit cycle with zero international or real-asset diversification
Q4 noninterest-bearing deposit surge flagged by management as unsustainable; Q1 2026 NIM expected to dip — execution risk on deposit guidance is front-and-center
Operating cash flow ($344M) materially below net income ($598M) — gap requires scrutiny; could reflect unrealized security losses, accrual items, or loan-level adjustments that mask true cash generation

Valuation Referee (Damodaran-style) — 🟡 watch · 52/100 · medium confidence

Valley National Bancorp is a bank, and the system-provided valuation block correctly flags that FCF-based DCF is not appropriate for banking. However, the Damodaran approach for banks is to value equity directly via a dividend discount / excess-return model using ROE vs. cost of equity, not an FCFF DCF. Sufficient data exists to run this framework. At $14.72, the stock trades at 1.01x book value ($7.81B equity, 555M shares → ~$14.06 book/share). With a reported ROE of 7.66% (FY2025) and management targeting adjusted ROE ~13%+ near-term and ~15% by 2027–28, the implied value under an excess-return framework depends critically on whether those ROE targets materialize. Cost of equity for a regional bank with beta ~1.04, using ERP ~5.5% and risk-free ~4.3%, is roughly 10%–11%. At current ROE of 7.66%, the bank is destroying value on a cost-of-equity basis (ROE < Ke), which should price it BELOW book — yet it trades at book. The market is pricing the forward ROE improvement, not the current ROE. If management achieves 13% ROE sustainably on ~$7.8B equity growing at mid-single digits, and the cost of equity is ~10.5%, the excess return per year is ~2.5% on equity (~$195M/year), discounted at Ke with a terminal growth of ~3%, yielding an equity value premium to book of roughly $195M / 0.075 = ~$2.6B, or ~$4.70/share premium over $14.06 book → intrinsic value ~$18–19/share at full execution. However, this demands: (1) ROE actually reaching 13–15% (requires NIM expansion of 15–20bp, credit normalization to ~100bp provision, and expense discipline — all management guidance, not proven), (2) sustained organic growth without capital dilution, and (3) no macro deterioration. The current $14.72 price implies modest expectations — roughly 9–10% forward ROE — which is achievable but not certain. The margin of safety is thin: the stock is at book, already up 75% in one year, and the bull case requires several simultaneous execution steps. The bear case (ROE stays 7–9%) implies a price well below book (~$10–12). This is a 'watch' — not obviously overvalued given the improving trajectory, but not cheap enough to have genuine margin of safety under conservative assumptions.

Key points

At 1.01x P/B and ROE of 7.66% (FY2025), the stock is currently priced ABOVE its economically justified value on a cost-of-equity basis (Ke ~10.5% >> current ROE), meaning the market is paying for forward ROE improvement — a bet, not a value
Excess-return model: if ROE reaches 13% sustainably on $7.8B growing equity, intrinsic value is approximately $18–19/share, implying ~25% upside — but this requires full execution of NIM expansion (15–20bp guided), credit normalization (provision ~$100M), and expense discipline simultaneously
Q1 2026 results: GAAP EPS $0.28 (+55.6% YoY), revenue $1.01B (+12.6% YoY) — momentum is real; Q4 2025 NIM 3.17% beat; deposit costs declining (24bp QoQ); credit metrics improving (criticized/classified loans -$350M)
The implied expectations in the current $14.72 price (~9–10% forward ROE) are modest and achievable — this is the key reason this is 'watch' rather than 'avoid'; the price does not demand heroic assumptions
Stock already up 75% one year and 23% YTD 2026; street targets $16; limited margin of safety — the conservative bear case (ROE stays low) puts intrinsic value at $10–12, a 20–30% downside from current price

Red flags

No margin of safety at current price: stock trades at book value, and any DCF/excess-return model requires ROE to improve materially from current 7.66% to justify the price — conservative assumptions do NOT support a buy
ROE < cost of equity today (7.66% vs ~10.5% Ke) means the bank is currently value-destructive on incremental equity; the entire bull case is forward-looking and execution-dependent
Management ROE targets (13% near-term, 15% by 2027–28) require simultaneous delivery on NIM (rate environment dependent), credit normalization, and operating leverage — each individually plausible but compound execution risk is elevated
$4B deposit growth achievement is real, but Q4 noninterest-bearing spike flagged by management as 'moderating in Q1' — key pillar of the NIM expansion thesis may soften faster than modeled
Stock has re-rated 75% in 12 months; any guidance miss (NIM below 3.3% target, provision above $100M, expense creep) could trigger a rapid re-rating downward given the forward expectations already embedded

Stanley Druckenmiller — 🟡 watch · 52/100 · medium confidence

VLY presents a genuine earnings inflection story — NIM expanding 15-20bp through 2026, EPS up 55% YoY in Q1 2026, deposit costs falling, and credit normalizing — but it falls short of the asymmetric, concentrated-bet setup I demand. The tape has already moved hard (up 75% over one year, 23% YTD 2026, now at 52-week highs at $14.72), meaning much of the earnings re-rating is already priced. Street targets cluster around $16, implying only ~9% upside from current levels — that is not the 3-5x asymmetry I need to size up. The second derivative on earnings is clearly positive (ROA at 1.14%, highest since Q4 2022; efficiency ratio compressing toward 50%; provision falling from 40bp to 24bp charge-offs), and the Fed is broadly in an easing posture (two cuts assumed in 2026), which is a tailwind for bank NIMs and a positive liquidity backdrop. The loan pipeline inflection (+70% YoY) and deposit mix shift are real fundamental improvements, not accounting noise. However, several Druckenmiller-style disqualifiers temper conviction: (1) The upside from here is modest and consensus — the $16 price target is now widely known, making this a crowded regional-bank recovery trade rather than a differentiated macro bet; (2) ROE at 7.7% trailing (even if accelerating toward management's 13%+ adjusted) is not the dominance profile I want in a concentrated position; (3) P/B at 1.01x is fair but not screaming margin-of-safety for a size-up after a massive run; (4) The thesis depends on two rate cuts materializing in 2026 — if the Fed holds or hikes, the deposit repricing and FHLB maturity tailwinds diminish materially; (5) The Q1 2026 NIM dip (seasonal) and NIB deposit moderation create near-term execution risk that could stall the tape. The stock is liquid (NASDAQ, ~$7.9B market cap), management communication is clear, and the balance sheet is readable — these are positives. But the defining issue is asymmetry: I want to be in the trade BEFORE the market has discounted it, not after a 75% run when every analyst is raising targets to $16. The edge has largely been captured by earlier entrants.

Key points

Earnings second derivative strongly positive: EPS +55% YoY Q1 2026, NIM expanding 15-20bp through 2026, provision guided down to ~$100M from elevated 2024 levels
Fed easing posture (two cuts assumed) directly benefits NIM via deposit repricing and FHLB maturity schedule ($600M at ~4.7% maturing in 2026) — monetary tailwind intact
Deposit inflection is real: $4B core deposit growth in 2025 (9% YoY), noninterest-bearing growing >15% annualized Q4, deposit costs fell 24bp sequentially — funding mix structurally improving
Loan pipeline up >70% YoY (+$1B), C&I accelerating, first sequential CRE growth in 18 months — loan growth catalyst beginning to compound with margin expansion
Operating leverage maturing: expense growth 2.6% vs revenue growth 9% FY2025; efficiency ratio compressing toward 50% — earnings power accelerating
Stock liquid ($7.9B market cap, NASDAQ) with clean, readable balance sheet — manageable position
Capital return ($150-200M buybacks + dividends) acts as EPS accelerant on improving base earnings

Red flags

Tape has already moved — 75% one-year gain, 23% YTD 2026, now at 52-week highs — much of the re-rating is complete; entering here means paying for the inflection, not anticipating it
Consensus has caught up: street targets at $16 imply only ~9% upside from $14.72 — asymmetry is gone for a concentrated bet; this is now a crowded regional-bank recovery trade
Rate-cut dependency: thesis relies on two Fed cuts in 2026; if macro stays hot or inflation re-accelerates and cuts don't materialize, NIM expansion and deposit repricing assumptions break materially
Q1 2026 NIM expected to dip from 3.17% (seasonal factors, NIB moderation) — near-term tape could soften before resuming, creating an entry-point problem at current levels
ROE at 7.7% trailing (even adjusted ~13% Q4) is not the dominant-franchise return profile that warrants a large concentrated position; management's 15% target is 2027-2028 — too far out for near-term catalyst sizing
Noninterest-bearing deposit surge in Q4 2025 flagged by management as likely to moderate — key driver of NIM beat could reverse, complicating Q1-Q2 2026 margin trajectory
Fee income lumpy and limited: Q4 benefited from episodic swap fees and FinTech equity gains; core fee growth muted vs loan/deposit momentum — revenue quality mixed

Benjamin Graham — 🟡 watch · 52/100 · medium confidence

Valley National Bancorp is a legitimate, established banking enterprise with a 10+ year operating history, consistent profitability, a dividend, and adequate size ($64B total assets, $7.9B market cap). It is properly assessed on P/B and ROE rather than a FCF-DCF. The quantitative picture is mixed from a Graham standpoint: P/B of 1.01x is near book value — a favorable signal — and trailing P/E of 13.16x sits modestly below Graham's defensive ceiling of 15x. The product of P/E × P/B (13.16 × 1.01 ≈ 13.3) comfortably clears the 22.5 threshold, satisfying Graham's combined valuation test. Net income of $598M in FY2025 represents strong recovery, with Q1 2026 EPS up 55% YoY, suggesting improving earnings trend. However, key Graham balance-sheet criteria cannot be cleanly applied to a bank: banks structurally invert the current-ratio test (deposits are liabilities, not working capital), and the net-net test is meaningless given $56B in liabilities vs. $64B total assets — leverage is the business model. The debt-to-equity ratio reported (0.21) appears to reflect only formal long-term debt, not the deposit funding base, which is the economically relevant liability. ROE of 7.66% is below my preference — it barely clears the cost of equity for a bank — though management guided toward 13%+ adjusted ROE in Q4 2025 and aspires to 15% by 2027/28. The stock has rallied ~75% in one year and 23% YTD 2026, trading at its 52-week high — precisely the condition Mr. Market is optimistic, not pessimistic — reducing margin of safety. Street targets at $16 imply only ~9% upside from $14.72. Dividend history is not fully detailed in the fact base, but the bank has multiple preferred series outstanding and common dividends appear continuous. Credit quality is improving (charge-offs 24bp vs. 40bp in 2024; classified loans declining). The margin of safety at current prices is thin: P/B near 1.0 is value-adjacent but not a deep discount, and the earnings multiple at 13x leaves little room for error if NIM expansion stalls or credit costs re-accelerate. I cannot award a 'pass' because the price has been bid up to fair value on improving fundamentals, not to a level where I am buying with a one-third margin of safety below conservative intrinsic value.

Key points

P/B of 1.01x and P/E of 13.16x satisfy Graham's combined test (P/E × P/B = 13.3, well below 22.5 ceiling)
FY2025 net income $598M; Q1 2026 EPS up 55% YoY — improving earnings trajectory over observable period
ROE 7.66% is below par for my standard but management guiding toward 13%+ adjusted, with inflection already visible in Q4 2025
$64B total assets, NASDAQ-listed, established 10+ year track record — adequate size and stability criteria met
Credit quality improving: net charge-offs declining to 24bp from 40bp; criticized/classified loans down $350M in Q4 2025
Preferred dividends and common dividend history suggest continuity of shareholder payments

Red flags

Stock at 52-week high after 75% one-year rally — Mr. Market is optimistic, not pessimistic; margin of safety is thin
No meaningful discount to book value: P/B of 1.01x is fair value, not the deep discount (below book or well below book) Graham demands for banks
Street consensus target ~$16 implies only ~9% upside — insufficient margin of safety for error absorption
Balance-sheet tests (current ratio, net current assets) not applicable to bank structure, creating analytical opacity for my framework
ROE of 7.66% on a trailing basis is below cost of equity; heavy dependence on forward margin-expansion thesis (15–20bp NIM expansion, two rate cuts) to justify current price
Fee income dependent on episodic items in Q4; core earnings quality requires further verification across a full cycle
Deposit cost beta and NIM assumptions are management projections, not demonstrated history — Graham prefers demonstrated results over forecasts

Peter Lynch — 🟡 watch · 52/100 · medium confidence

Valley National Bancorp is a regional bank turnaround story transitioning toward a stalwart/turnaround hybrid. The Lynch framework applies — the story is understandable (relationship banking model fixing its deposit mix, expanding NIM, and compressing its efficiency ratio toward 50%), and there is a traceable earnings-growth narrative. Q1 2026 EPS of $0.28 was up 55.56% YoY, and FY2025 net income hit $598M. However, the Lynch lens is uncomfortable here for several reasons. PEG calculation: P/E is ~13.2x (price $14.72, net income $598M on ~555M shares = ~$1.08 EPS). EPS growth of 55% in Q1 2026 YoY is partly a low-base effect from a challenging 2024; forward EPS growth is likely to normalize to 15-20% as NIM expands 15-20bp and loan growth hits mid-single digits. Using a generous 18% forward growth estimate, PEG = 13.2/18 = 0.73 — that is actually attractive by Lynch standards. Adding the dividend yield (approximately 3-4% given historical bank dividend patterns, though exact yield not confirmed in the fact base) pushes yield-adjusted PEG even lower toward 0.5-0.6. This is the strongest point in VLY's favor. Category classification: This is a turnaround/stalwart hybrid. The bank has grown its balance sheet from $20B to $64B but is now in a profitability-repair phase — adjusted ROA reached 1.14% (highest since Q4 2022), ROE at 7.7% on reported basis but 13%+ adjusted in Q4 2025, with management targeting 15% by late 2027/early 2028. For a turnaround, Lynch requires seeing the actual turn underway — and that is clearly happening: criticized/classified loans down $350M in Q4, charge-offs falling from 40bp (2024) to 24bp (2025), core deposit growth of $4B (9% YoY). The story is believable and traceable. Balance sheet concern: For a bank, debt-to-equity of 0.21 on reported long-term debt looks fine, but total liabilities of $56.3B against $7.8B equity (leverage ratio ~7.2x) is standard banking leverage but still a Lynch concern given the inherent opacity of bank balance sheets. The $64B asset base with $1.65B long-term debt (excluding deposits as funding) is manageable; FHLB advances of $600M at 4.7% maturing in 2026 are a known positive catalyst. Understandability: Valley does relationship banking in NJ, NY, FL, CA with a C&I/CRE mix — straightforward enough. The 'story' is: deposit mix fixed, margins expanding, credit healing, efficiency compressing, and buybacks adding per-share value. Negatives from Lynch lens: (1) Stock is up 75% in one year and 23% YTD 2026 — the neglected-stock edge is largely gone, with analyst targets now at $16 and institutional buying noted. The easy money has already been made. (2) The Q4 fee income boost from swap fees and FinTech gains is exactly the kind of one-time gain Lynch flags as opaque. (3) Management's 'no M&A' stance is encouraging (no diworsification risk), and buybacks are supportive. (4) Price-to-book of 1.01x is nearly at tangible book — for a bank generating 13%+ adjusted ROE, this is fair but not deeply cheap. (5) Earnings-growth deceleration risk: if NIM expansion of 15-20bp is back-loaded and Q1 2026 dips, the YoY EPS comps become harder in H2 2026. The turnaround is real but the valuation gap has meaningfully closed.

Key points

PEG approximately 0.73 using ~13.2x P/E and ~18% forward EPS growth — within Lynch's acceptable range, especially yield-adjusted
Turnaround/stalwart category: profitability inflection clearly underway with ROA 1.14% (highest since Q4 2022) and charge-offs falling from 40bp to 24bp
Core deposit growth of $4B (9% YoY) in 2025 — the fundamental fix driving NIM expansion of 15-20bp in 2026
Understandable story: relationship bank repairing funding mix, expanding margins, compressing efficiency ratio toward 50%
No M&A distraction (management explicit); buybacks of $150-200M in 2026 support per-share earnings growth
Price-to-book ~1.01x for a bank targeting 13-15% ROE is reasonable; not deeply cheap but not stretched

Red flags

Stock up 75% in one year and 23% YTD 2026 — the neglected/undiscovered angle is largely gone; analyst targets now at $16 with institutional buying noted, limiting Lynch's 'under-followed' premium
Q4 fee income inflated by episodic swap fees and FinTech valuation gains — exactly the one-time opacity Lynch flags; core fee baseline more modest
Q1 2026 NIM expected to dip before recovering — near-term earnings momentum may disappoint momentum buyers and create volatility
Bank balance sheet opacity: $64B assets with standard ~7x leverage makes independent credit assessment difficult; CRE concentration risk remains even as management guides 'modest improvement'
EPS growth rate of 55% YoY in Q1 2026 is partly a low-base effect; sustainable normalized growth of 15-20% still supports PEG math but is less exciting than headline growth suggests
Exact dividend yield not confirmed in fact base — yield-adjusted PEG estimate is approximate

Michael Mauboussin — 🟡 watch · 52/100 · medium confidence

Valley National Bancorp is a mid-sized regional bank (~$64B assets) that sits in an analytically tractable but competitively difficult space for quality analysis. The core question is whether VLY earns a durable ROIC-above-WACC spread, and the evidence is mixed. ROE of 7.7% (FY2025 reported) is below typical bank cost of equity (~9-11%), though the Q4 2025 adjusted ROA of 1.14% and Q4 adjusted ROE of 13%+ suggest the earnings trajectory is inflecting. The moat analysis is the crux: regional banking offers genuine but narrow switching costs (relationship banking, embedded treasury/payment systems, loan covenants) and some scale economies in compliance/technology, but zero network effects and limited intangibles. VLY's specific moat sources — relationship commercial banking, geographic diversification post-Leumi, and a growing C&I franchise — are real but thin and replicable. The expectations embedded in the current price (~1.01x book, P/E ~13x) are relatively modest, implying the market is not yet pricing in full ROE normalization toward management's 15% target. This is the key: if management delivers 15% ROE sustainably, the stock is cheap at 1x book; if ROE reverts to 8-9%, the current valuation is roughly fair. The $4B core deposit growth in 2025 is the most concrete evidence of the relationship banking model working, reducing funding costs and improving NIM trajectory (3.17% Q4 2025, guiding 15-20bp expansion). However, the outside-view base rate for regional banks sustaining 15% ROE is poor — post-2008 and post-2023 crises, most reverted to 8-12% through cycle. Credit normalization is a real but unpredictable risk. The 75% one-year price rally has compressed the margin of safety. The fact base is missing detail on criticized/classified loan composition, CRE concentration metrics, and precise NIM sensitivity tables, limiting confidence in the credit and margin distribution tails.

Key points

ROE inflecting: Q4 2025 adjusted ROE ~13%, up from trough; management targets 15% by 2027-28. At 1.01x book, this implies a reasonable but not compelling margin of safety against cost of equity of ~10%
Moat is narrow and primarily switching-cost based: relationship commercial banking, embedded treasury/payment services, and multi-product cross-sell create modest customer stickiness. No network effects; limited intangibles. Moat trajectory: stable-to-improving as C&I mix grows
Expectations in price are moderate: P/E ~13x, P/B ~1x implies market is skeptical about sustainable ROE above cost of equity. If 2026 NIM guidance (15-20bp expansion) and credit normalization deliver, embedded expectations are beatable
Deposit franchise inflection is the highest-quality signal: $4B core deposit growth (9% YoY), falling deposit betas (55% actual vs 60% prior cycle), and noninterest-bearing growth are leading indicators of funding-cost moat
Operating leverage real: expense growth 2.6% vs revenue growth 9% in 2025; efficiency ratio trending toward 50%. Management tripled balance sheet ($20B to $60B) with only modest headcount growth — evidence of process discipline
$150-200M buyback program at ~1x book is capital allocation that creates value (buying below intrinsic value if ROE target is achievable) — positive signal on management process

Red flags

ROE spread over cost of equity is thin or negative on trailing basis (7.7% reported ROE vs ~10% cost of equity); the 15% target requires execution across multiple uncertain variables simultaneously
Regional banking has no defensible moat mechanism against larger, better-capitalized competitors (JPMorgan, BofA) expanding into VLY's NJ/NY/FL markets. Scale economics favor mega-banks in technology and compliance
Outside-view base rate is unfavorable: regional banks rarely sustain 15%+ ROE through a full cycle. Loan growth, NIM expansion, and credit quality rarely all move favorably simultaneously — the 2026 guidance assumes benign macro
CRE concentration remains elevated despite portfolio management; any commercial real estate stress (office, retail, multi-family) in NJ/NY/FL markets would pressure credit costs and reverse the 24bp charge-off improvement
The 75% one-year price rally means expectations are no longer pessimistic — the market has partially re-rated the story; street targets of $16 imply only ~9% upside from current $14.72, a poor risk/reward for the execution risk embedded in the bull case
Q4 2025 fee income included episodic swap gains and FinTech equity valuation gains — stripping these reveals that core fee growth is modest, limiting revenue diversification and making NII the dominant (and rate-sensitive) driver
Missing data: CRE concentration ratio, specific criticized/classified loan detail, NIM rate sensitivity table (parallel shift scenarios), and ROIC on incremental capital deployed post-Leumi acquisition — all limit confidence in the tail risk assessment

Warren Buffett — 🟡 watch · 48/100 · medium confidence

Valley National Bancorp is a regional bank — a business I can understand, though banking is more complex than I prefer. Banks operate with inherent leverage (this one: ~$64B assets against ~$7.8B equity, roughly 8:1), which means management quality and credit discipline are paramount — a mistake with the liability structure or loan book can wipe out years of earnings overnight. On my key criteria: ROE is 7.66% reported (well below my 15% threshold), though management targets 15% by late 2027/early 2028 — that's a forward promise, not a proven track record. P/B is essentially 1.0x, which for a bank earning sub-8% ROE is arithmetically sensible but offers no particular value creation story. The business model is understandable — gather deposits, make loans, earn spread — but Valley's competitive moat is questionable. Regional banks rarely possess durable moats; competition for deposits and loans is fierce, switching costs are low, and pricing power is minimal. The deposit franchise improvements (nearly $4B core deposit growth in 2025) are encouraging, but one strong year doesn't establish durability. Net income of $598M in FY2025 is meaningful, but free cash flow ($326M) diverges from net income significantly, which in banking reflects the capital-intensive nature of growing the loan book. The 13.2x P/E is not expensive for a bank, but the low ROE means book value compounding will be slow. Management's Q4 2025 earnings call narrative is optimistic — NIM expansion guidance of 15-20bp, efficiency ratio trending toward 50%, expense discipline — and Q1 2026 showed 55% YoY EPS growth ($0.28). However, the stock has already rallied ~75% in one year and ~23% YTD, so the 'improving story' is partly priced in. The balance sheet carries $1.65B long-term debt (modest relative to equity), but total liabilities of $56B vs. equity of $7.8B means the institution is highly leveraged as banks inherently are — not a red flag per se, but it confines my enthusiasm. Capital allocation appears disciplined: $150-200M annual buybacks, stable dividends, no M&A plans, CET1 maintained 10.5-11%. Management's candor about Q1 seasonality and NIB deposit moderation is a positive honesty signal. However, the 'turnaround/improvement story' framing — rather than a proven, steady 15%+ ROE compounder — is exactly the kind of situation I've historically avoided. I need to see sustained, proven economics, not a glide path to better returns.

Key points

ROE of 7.66% is well below my 15% threshold; management targets 15% by 2027-2028 but this is aspiration not proven history
P/B of ~1.0x is fair for a sub-8% ROE bank but implies no economic moat premium
Q4 2025 record net income $195M; FY2025 $598M net income with improving efficiency ratio trending toward 50%
Strong deposit franchise improvement ($4B core deposit growth, 9% YoY) is encouraging but one-year data point
Manageable long-term debt ($1.65B); CET1 at 10.5-11% target range; $150-200M buyback program disciplined
Q1 2026 EPS up 55% YoY shows momentum, but stock already up 75% over one year reducing margin of safety
Management appears honest and candid; no M&A distraction; organic growth focus is rational capital allocation

Red flags

No identifiable durable competitive moat — regional banking is highly competitive with minimal switching costs or pricing power
ROE chronically below 15%; the bank is still in 'improvement mode' rather than proven compounder status
Stock up ~75% in one year means the improving story is substantially priced in; margin of safety is thin at ~1.0x book
Earnings improvement narrative depends on rate assumptions (two 2026 cuts), NIM expansion execution, and deposit beta discipline — multiple variables outside management control
High institutional leverage inherent to banking (8:1 assets/equity) amplifies credit risk; any credit deterioration is magnified
Free cash flow ($326M) well below net income ($598M) — capital consumption of loan growth limits true owner earnings
Outside my strongest circle of competence — bank credit books and interest rate management require specialized expertise to assess confidently

Seth Klarman — 🟡 watch · 48/100 · medium confidence

Valley National Bancorp trades at 1.01x tangible book value (~$14.72 vs. book ~$14.05/share implied by $7.81B equity / 555M shares), which on the surface looks like a modest asset-backed anchor. However, from a Klarman margin-of-safety perspective, paying book for a regional bank fails the discount test — especially when book value includes goodwill and intangibles from acquisitions (Leumi, etc.) that may not survive a liquidation or stress scenario. The DCF is correctly flagged as inapplicable. The proper valuation anchors for a bank are P/B (currently ~1.01x) and ROE (7.66% trailing, below cost of equity for most regional banks). An ROE of 7.66% does not justify book value, let alone a premium. Normalized ROE is improving (management targets 13%+ adjusted, 15% by 2027/28), but those are aspirational forward numbers dependent on margin expansion, deposit behavior, and benign credit — exactly the kind of optimistic scenario Klarman discounts heavily. On the positive side: the bank has made genuine operational progress (NIM expanding to 3.17%, $4B core deposit growth, charge-offs declining from 40bp to 24bp, criticized/classified loans falling $350M in Q4 2025, CET1 in 10.5–11% target range, no near-term liquidity crisis). The loan pipeline is strong and management commentary is credible. But VLY has already rallied ~75% in one year and ~23% YTD 2026, and trades at the 52-week high. The margin of safety that may have existed at $8–9 levels is largely gone. Street targets of $16 imply only ~9% upside from current price, and those targets rest on continued execution of forward guidance — mid-single-digit loan growth, 15–20bp NIM expansion, sub-$100M provision, low-single-digit expense growth — all of which embed meaningful execution risk. The bear case (deposit repricing fails, rate cuts don't materialize, CRE stress re-emerges, episodic fee income doesn't recur) does not preserve capital at 1.01x book when book itself may be impaired. The bank is large ($64B assets) with $56.3B in liabilities vs. $7.8B equity — a 12:1 leverage ratio typical of banks but a genuine Klarman red flag. Long-term debt data appears stale (2018 period cited), reducing confidence. Net income of $598M is real but FCF of $326M is well below, and operating cash flow of $344M is supported by operating assumptions that may not hold in a downturn. No special-situation catalyst (spin-off, restructuring, distress, forced selling) creates asymmetric value here — this is a recovering regional bank being repriced by the market for improving fundamentals, which is precisely the kind of momentum-driven re-rating Klarman avoids. I hold this as a watch rather than an avoid because the operational improvement is genuine and book value provides some floor, but at current prices there is insufficient margin of safety to deploy capital.

Key points

Trades at ~1.01x book value — no discount to conservative asset value; Klarman demands a meaningful margin of safety below intrinsic value, not fair value
Trailing ROE of 7.66% is below typical cost of equity for regional banks, meaning the bank does not earn its cost of capital at current book multiples; forward ROE targets (13–15%) are aspirational and execution-dependent
Stock has already rallied 75% in one year from distressed levels near $8.77; the mispricing that created opportunity has largely been arbitraged away by the market
Operational improvement is genuine: NIM at 3.17%, core deposit growth $4B (9% YoY), charge-offs declining, CET1 in target range, efficiency ratio moving toward 50% — the fundamentals are improving but are now priced in
No special-situation catalyst or structural forced-selling dynamic present; this is a straightforward fundamental re-rating, not the asymmetric special-situation Klarman values
Balance sheet leverage is 12:1 (assets/equity), standard for banks but a structural downside risk that limits the 'floor' value in stress scenarios
Street price targets at $16 imply only ~9% upside from $14.72 — asymmetry is unfavorable for a Klarman-style position
Long-term debt and cash data in the fact base appears stale (2018 periods), reducing confidence in precise balance sheet assessment

Red flags

No margin of safety: stock at 1.01x book after a 75% one-year rally means paying full value for an improving-but-still-below-cost-of-capital bank
Value thesis depends on forward guidance execution (15–20bp NIM expansion, 13%+ ROE, controlled credit losses) — precisely the kind of optimistic scenario Klarman stress-tests away
Balance sheet includes goodwill/intangibles from acquisitions (Leumi etc.) that inflate book value and may not hold in a true liquidation or stress scenario — the downside floor is partially fictional
Episodic Q4 fee income (swap fees, FinTech equity gains) inflates recent earnings quality; core run-rate is lower than reported
12:1 leverage (56.3B liabilities / 7.8B equity) leaves minimal cushion if deposit repricing, credit quality, or rate assumptions disappoint
Stale balance-sheet data (cash and LT debt reported as of 2018) in the fact base creates analytical uncertainty about true liquidity position
No catalyst to force value realization — patience is required with no hard event to close any remaining discount
Retail sentiment and momentum-driven buying (options chatter, M&A speculation, $20 price targets on StockTwits) are classic Klarman red flags of crowd behavior masking fundamental analysis

Walter Schloss — 🟡 watch · 48/100 · medium confidence

Valley National Bancorp is a bank, which sits in a gray zone for my approach. I can engage because there is a full balance sheet, tangible book value is calculable, and the stock has a multi-year price history showing a significant recovery from deep lows. However, my framework must be adapted: bank leverage is structural (deposits are liabilities, not debt in the industrial sense), so I cannot penalize it as I would a manufacturer. The relevant anchors for a bank are price-to-book, ROE vs. cost of equity, and asset quality. At $14.72 with book value of approximately $7.808B on ~555M shares outstanding, tangible book per share is roughly $14.06 (stockholders' equity $7.808B divided by 555.4M shares), putting price-to-book at approximately 1.01x — barely above book. That is modestly attractive on a Schloss asset basis, not a screaming bargain but not egregiously overpriced on hard assets either. The critical Schloss problem here is that the stock has already run approximately 75% over one year and is sitting at or near its 52-week high of $14.72-$14.94. This is precisely the opposite of what I buy — I want beaten-down, forgotten names near multi-year lows, not stocks that have already been re-rated by the market. The margin of safety from depressed price is largely gone. ROE of 7.66% reported (though Q4 2025 annualized adjusted ROE was ~13%) is mediocre by industrial standards but improving. The balance sheet is inherently levered (~8.8x assets to equity, total liabilities $56.3B vs. equity $7.8B), which is normal for banking but uncomfortably high for my framework. Long-term debt in the disclosed recent figures is moderate at $1.65B, though this figure appears to be from 2018 data — the FHLB advances and borrowing structure for a $64B bank are substantially larger and not fully visible here. Credit quality is improving (criticized/classified loans down $350M, NCOs declining to 24bp from 40bp). The dividend appears to be paid (preferred stock series A, B, C noted; common dividend implied by capital return discussion). The thesis relies significantly on management's NIM expansion story, loan pipeline growth, and deposit repricing — exactly the kind of earnings-forecast dependency I distrust. I cannot verify the assets are conservatively marked; CRE concentration is a latent risk. The fact that analysts are raising targets to $16 and the stock is up 23% YTD tells me the easy money has been made. I would have wanted this at $8-10 (near the 52-week low of $8.77), not at $14.72 near the high.

Key points

Price-to-book approximately 1.01x (price $14.72 vs. ~$14.06 tangible book/share calculated from $7.808B equity / 555.4M shares) — marginally above book, not the deep discount I require
Stock is at its 52-week HIGH of $14.72, up ~75% over one year — diametrically opposed to my buy-near-lows philosophy
ROE improving (Q4 annualized adjusted ~13%) but full-year reported ROE only 7.66%, barely covering cost of equity
Credit quality genuinely improving: NCOs 24bp (down from 40bp in 2024), criticized/classified loans down $350M in Q4 alone
Core deposit growth of $4B (9% YoY) reduces reliance on expensive brokered funding — a real balance sheet improvement
$150-200M buybacks planned for 2026 with CET1 in 10.5-11% range provides some capital return discipline

Red flags

Stock near 52-week high — no margin of safety from a depressed price; Schloss bought out-of-favor names, not momentum stocks
Thesis depends heavily on management forecasts: NIM expansion 15-20bp, mid-single-digit loan growth, deposit beta assumptions — all earnings-story dependent, not asset anchored
Inherent banking leverage (total assets $64B vs. equity $7.8B = ~8.2x) is structural but uncomfortable; FHLB advances, brokered deposit reliance not fully transparent in available data
CRE concentration risk: even as management runs off non-relationship CRE, the portfolio remains large relative to capital — latent credit risk if commercial property values deteriorate
Cash and equivalents reported as $428M from 2018 period data — balance sheet data appears partially stale/mismatched in the fact base, reducing confidence in asset verification
Insider ownership data not available in the fact base — cannot confirm management alignment with shareholders
Goodwill and intangibles from prior acquisitions (Leumi, others) likely embedded in book value, meaning tangible book per share may be materially lower than stated ~$14.06

Forensic Short-Seller (Chanos/Einhorn-style) — 🟡 watch · 48/100 · medium confidence

Valley National Bancorp is a regional bank, so classical forensic short-selling tools (DSO, inventory, capitalised costs, SBC dilution) have limited applicability compared to industrial or tech names. However, the core earnings-vs-cash test is meaningful and raises modest flags. Net income for FY2025 was $597.9M while operating cash flow was only $343.8M — a substantial gap of ~$254M, meaning reported earnings exceed CFO by roughly 74%. Free cash flow ($325.7M) also trails net income significantly. For a bank, some divergence between GAAP net income and operating CFO is expected (loan originations flow through investing, not operations), but the magnitude here warrants attention. The P/B ratio of ~1.01x and P/E of 13.2x are not bubble-level, which limits the short appeal. That said, the NIM expansion story (15-20bp guided) rests on multiple assumptions (two rate cuts, beta outperformance, FHLB repricing) that could disappoint. The Q4 2025 noninterest-bearing deposit surge was flagged by management itself as likely to moderate — if that reversal is sharper than expected, the NIM tailwind compresses. Credit quality improvement (charge-offs 24bp vs 40bp in 2024) is encouraging but the 'improving trend' narrative is a common pre-stress signal; CRE exposure remains a latent risk. The $7.8B stockholders' equity vs $64.1B total assets (12.2% equity/assets) is adequate but not generous for a bank with CRE concentration. One large C&I credit moved to nonaccrual in Q4 was flagged as isolated — forensic discipline demands skepticism of that framing without full loan tape data. Insider activity and auditor data are not available in the filing excerpts provided, limiting the governance check. The stock is at a 52-week high with a 75% one-year rally — momentum risk is real if any guidance element slips. The kill question: the short thesis triggers if (1) core deposit growth reverses and funding costs re-accelerate, (2) CRE credit deterioration exceeds provision guidance of ~$100M, or (3) NIM expansion fails to materialise and Q1-Q2 2026 NII disappoints, reversing the re-rating. Disproved if deposit growth sustains >5% NIB and NIM reaches 3.30%+ by Q3 2026.

Key points

Net income ($598M) exceeds operating cash flow ($344M) by ~$254M — a 74% earnings-to-CFO gap that warrants scrutiny even adjusting for banking norms
FCF ($326M) also substantially below reported net income, accrual ratio elevated
Q4 noninterest-bearing deposit spike explicitly flagged by management as unsustainable — key pillar of NIM expansion thesis at risk
NIM 15-20bp expansion guidance depends on two rate cuts, beta outperformance, and FHLB/fixed-rate loan repricing coinciding — multiple simultaneous assumptions
CRE still a large portfolio concentration; sequential CRE growth resumed in Q4 after 18 months of runoff — re-exposure risk
Stock up 75% one-year, now at 52-week high — limited margin of safety if any guidance element slips
$100M provision guidance for 2026 assumes credit normalisation; one C&I nonaccrual move in Q4 described as isolated without independent verification

Red flags

Net income materially exceeds operating cash flow — core quality-of-earnings flag for forensic analysis
Management's own Q4 NIB deposit growth caveat undermines the durability of the funding cost improvement narrative
CRE concentration resuming growth after strategic runoff — potential for vintage 2026 losses in 2027-2028
Lack of insider Form 4 data in filing excerpts prevents governance check — absence of data, not absence of risk
Non-GAAP adjusted figures cited prominently (adjusted ROA 1.14%, adjusted EPS $0.31 vs GAAP $0.33) — gap is small but pattern of non-GAAP reliance in bank narratives warrants monitoring
Stock momentum and analyst re-rating to $16 price targets creates air pocket risk if Q1/Q2 2026 NIM disappoints

Charlie Munger — 🟡 watch · 45/100 · medium confidence

Valley National Bancorp is a regional bank — a business I can understand in broad strokes (take deposits, make loans, earn the spread), but banking is an inherently leveraged, opaque business that sits near the edge of my circle of competence. Banks are not black boxes per se, but the complexity of a $64B asset institution with CRE concentration, multiple preferred stock series, and a book dominated by loans and securities means the quality of the franchise is genuinely hard to judge from the outside. Applying my quality lens here: the business earns a 7.66% ROE currently — well below my 15%+ threshold for a great business. Management is guiding toward 13%+ adjusted ROE and aspirationally toward 15% by late 2027/2028, but that is a promise, not a demonstrated track record. The moat question is the central problem: regional banks have no durable pricing power moat. Depositors can move funds, and loan pricing is set by competitive markets. VLY's 'relationship banking' differentiation is real but fragile — not the kind of switching-cost or brand moat I'd pay up for. The deposit-growth achievement ($4B core deposits, NIB surge) is genuinely impressive operationally, but whether it represents durable franchise value or cyclical repositioning is unclear. On the positive side: management at Q4 2025 earnings was candid and specific (NIM targets, capital allocation framework, explicit provision guidance), which I respect. Expense discipline — 2.6% cost growth vs. 9% revenue growth — suggests operational rationality. CET1 at 10.5-11% is conservative for a bank this size. The stock at ~1.01x book and 13x trailing P/E is not obviously expensive for the quality on offer. But the stock has run 75% in one year and 23% YTD — the margin of safety has compressed substantially. At current prices, I am not being paid to take banking's inherent risks (credit cycle, rate sensitivity, regulatory capital calls, deposit flight). The inversion test — how does this go wrong? Credit cycle turns, CRE losses emerge, NIB deposits flee, and a bank levered 7:1 on equity can erode book value rapidly. That is not a remote scenario for a regional bank with meaningful CRE exposure. I would want to own this at a more substantial discount to tangible book and only after seeing the ROE durably clear 13-15% through a full credit cycle.

Key points

ROE of 7.66% is well below my 15%+ quality threshold; management targets ~13% adjusted ROE in Q4 2025 and aspirationally 15% by 2027-2028 — not yet demonstrated
P/B of 1.01x and P/E of 13x not expensive in isolation, but stock is up 75% one-year and 23% YTD, compressing margin of safety materially
Deposit franchise improvement ($4B core deposit growth, 9% YoY) is operationally impressive and reflects execution, but relationship banking is not a durable moat in my framework — no pricing power, no switching costs
Expense discipline demonstrated: 2.6% cost growth vs. 9% revenue growth; efficiency ratio trending toward 50%; management appears rational and candid in disclosures
NIM expansion guide of 15-20bp (Q4-to-Q4 2026) depends on two Fed cuts, repricing assumptions, and competitive deposit environment — multiple dependencies
CET1 at 10.5-11% is prudent; $150-200M buyback plan reasonable; no aggressive M&A signaled — capital allocation is sensible
Credit metrics improving: NCOs fell from 40bp (2024) to 24bp (2025); criticized/classified loans down $350M in Q4; $100M provision guidance implies normalization

Red flags

Banking is inherently opaque and leveraged — sits at the edge of my circle of competence; $64B balance sheet levered ~8:1 means errors are magnified
No durable moat: regional banks face commodity deposit/lending markets; 'relationship banking' is a positioning, not a structural barrier
Current ROE (7.66%) well below cost of equity for a regional bank — not yet a great business even if trajectory is improving
75% one-year stock rally means the easy money has been made; at $14.72 near 52-week high, margin of safety is thin
CRE exposure remains significant; one credit cycle turn could impair book value materially — the inversion test reveals real downside
Fee income lumpiness: Q4 benefited from episodic swap fees and FinTech gains — core earnings quality lower than headline suggests
Preferred stock series A/B/C in capital structure adds complexity and dilution risk to common equity holders

Chuck Akre — abstained

Valley National Bancorp is a regulated commercial bank — precisely the balance-sheet-driven, leverage-intensive business category where my framework explicitly does not apply. Banks are not capital-light franchise businesses; their ROE is inherently a function of leverage (12:1+ assets-to-equity), their 'earnings' are not freely reinvestable cash flows in the Akre sense, and the accounting conventions (loan-loss provisioning, mark-to-market securities, regulatory capital ratios) make it impossible to reliably assess the 'return on owners' capital' that drives my three-legged stool analysis. VLY's reported ROE of ~7.7% looks below my 20%+ threshold, but even evaluating this meaningfully requires a completely different analytical framework (P/B vs. ROE spread, tangible book accretion, NIM analysis) that is not my school. The valuation block itself flags DCF as not applicable for banks. Engaging here would be stretching my criteria to force a verdict on a fundamentally incompatible business model — exactly what the council rules prohibit.

Key points

Banking is explicitly listed as a category where I abstain — balance-sheet-driven, leverage-dependent ROE, not a capital-light franchise
VLY's reported ROE of ~7.7% is well below my ~20%+ bar, but even this comparison is meaningless given bank leverage conventions
FCF-based analysis inapplicable (valuation block confirms); bank 'earnings' are not the free-cash-flow-compounding engine my framework requires
The three-legged stool cannot be evaluated: 'capital-light' is definitionally absent, reinvestment runway analysis requires bank-specific metrics I don't employ
No insider ownership, pricing power, or switching-cost moat analysis translates cleanly from my consumer/franchise/software framework to a regulated deposit-taking institution

Red flags

Leverage is structural and extreme (~8:1 equity multiplier) — my primary red flag triggers immediately
ROE at 7.7% is well below cost of capital by Akre standards, even if improving toward management's 13-15% target
Highly regulated industry limits capital allocation flexibility and reinvestment optionality that I prize
Deposit competition and rate sensitivity create earnings cyclicality inconsistent with the predictability I require for long-hold ownership

Philip Fisher — abstained

Valley National Bancorp is a regional commercial bank — a fundamentally different business model from the growth companies Fisher's framework was designed to evaluate. Fisher's 15-point scuttlebutt method was built for manufacturing, technology, and consumer product companies with identifiable R&D pipelines, product innovation cycles, expanding addressable markets, and proprietary competitive advantages rooted in invention or distribution. VLY has none of these characteristics. It is a spread-banking business whose 'product' is a commodity (money), whose growth is constrained by capital requirements and interest rate cycles, and whose competitive differentiation rests on deposit relationships and credit underwriting discipline rather than R&D or product innovation. There is no R&D line item to assess, no product pipeline to scuttlebutt, and no above-industry organic sales growth driven by new markets or inventions. The 9% YoY NII growth and 7% annualized loan growth are respectable for a bank but are functions of interest rate positioning and balance sheet leverage — not the kind of durable, compounding organic growth from innovation that Fisher sought for decades-long holds. Fisher explicitly avoided cyclical and commodity businesses; a regional bank whose economics are fundamentally tied to the Fed funds rate, credit cycles, and deposit competition is precisely the category he would have set aside.

Key points

No R&D pipeline or product innovation cycle exists — the core Fisher screen is inapplicable by definition
Revenue growth (9% NII, 7% loan growth) is interest-rate and balance-sheet driven, not product/market-expansion driven
Competitive differentiation is relationship banking and credit underwriting, not proprietary technology or unique products
Business is inherently cyclical and commodity-like in its core spread-banking economics
Fisher's multi-decade holding thesis requires a franchise that compounds internally at high ROE via reinvestment — banking ROE (7.7% reported, 13%+ adjusted) is adequate but not exceptional enough to justify the framework given structural constraints

Red flags

Banking is explicitly the type of cyclical, commodity-spread business Fisher avoided in favor of growth franchises
No scuttlebutt method applicable — no customers evaluating a proprietary product, no supplier chain, no R&D scientists to interview
NIM expansion story (3.17% → mid-330s) is an interest rate positioning trade, not a durable competitive moat
Stock up 75% in one year suggests most of the easy re-rating may already be priced in — not a Fisher-style entry point even if the business qualified

Joel Greenblatt — abstained

Valley National Bancorp is a bank — precisely the category my framework explicitly excludes. For financial institutions, ROIC (EBIT / net working capital + net fixed assets) and EV/EBIT (the two Magic Formula inputs) are not meaningful or calculable in any trustworthy way. Banks do not have net working capital in the traditional sense; their 'inventory' is loans funded by deposits, interest expense is a cost of goods, not a financing cost, and the balance sheet is entirely financial assets and liabilities that cannot be separated into operating capital vs. financing capital. EV itself becomes distorted because deposits are simultaneously a funding source and an operating liability. The valuation block in this fact base correctly flags DCF as not applicable for the same structural reason. I have no reliable EBIT numerator or invested-capital denominator to construct either ratio. There is no special-situation angle (spinoff, restructuring, bankruptcy emergence) that would bring this into my special-situations playbook — VLY is an ongoing regional bank. Forcing a verdict would require guessing at numbers that have no valid analog to the framework, which I will not do.

Key points

Banks are explicitly excluded from the Magic Formula framework — ROIC and EV/EBIT are not computable in a meaningful way for financial institutions
Deposits are simultaneously operating and financing liabilities, making EV construction unreliable
Net working capital is not a sensible concept for a balance sheet composed entirely of financial assets
No special-situation catalyst (spinoff, restructuring, recapitalization) is present to invoke the alternative playbook
The fact base's own valuation block correctly abstains on DCF grounds for the same structural reason

Red flags

Financial institution — core Magic Formula inputs (EBIT/ROIC and EBIT/EV) are distorted and uncomputable
No special-situation angle to justify engagement outside the standard framework
Applying the formula here would produce numerically arbitrary, misleading outputs

Bruce Greenwald — abstained

Valley National Bancorp is a banking institution, and Greenwald's EPV/asset-reproduction methodology is explicitly not applicable to banks and financial intermediaries. The core reason: banks' earnings cannot be separated from their balance sheet leverage and funding mix the way industrial-company NOPAT can be isolated. Asset reproduction value for a bank is essentially book value (regulatory capital + deposit franchise), which is already captured by P/B — not by a capex-adjusted reproduction cost analysis. The DCF valuation block itself flags this: 'FCF-based DCF is not appropriate for Banking.' The same structural impediment applies to EPV capitalization: a bank's 'distributable earnings' cannot be normalized independent of its leverage, interest-rate positioning, and credit cycle — all of which are regime-dependent. Attempting to capitalize VLY's $598M net income or $326M FCF at a WACC to derive EPV would be methodologically meaningless without first stripping out the leverage embedded in a $64B asset base funded at ~8.8x equity. The correct valuation framework here is P/B vs. ROE-through-cycle (a bank earns its cost of equity when ROE = COE), P/E on normalized earnings, and NIM/credit-cost decomposition — none of which are Greenwald's EPV/asset-reproduction toolkit. The moat-test question (EPV vs. reproduction value) is similarly ill-posed for banking: a deposit franchise's 'reproduction cost' is a function of branch networks, regulatory capital, and decades of customer relationships — not the kind of tangible/intangible asset stack that the reproduction-cost method is designed to estimate. I abstain rather than force an inappropriate framework onto a regulated financial intermediary.

Key points

EPV methodology requires separable operating earnings independent of balance sheet leverage — impossible for a levered bank with $64B in assets at ~11x equity
Asset reproduction value analysis is not meaningful for deposit-funded financial intermediaries — book value already proxies this
The fact base's own valuation block confirms DCF/FCF approaches are not applicable to banking
Correct bank valuation rests on P/B vs. sustainable ROE, NIM trajectory, and credit-cycle normalization — outside Greenwald's toolkit
Abstaining preserves analytical integrity; forcing a verdict here would generate noise, not signal

Red flags

Attempting to apply EPV to a bank would import false precision and likely misstate intrinsic value by orders of magnitude
No EPV/asset-reproduction cross-check can be performed without stripping leverage, which fundamentally changes the analysis into something other than Greenwald's method

Terry Smith (Fundsmith) — abstained

Valley National Bancorp is a commercial bank — precisely the type of capital-intensive, leveraged, cyclical business that Terry Smith explicitly excludes from Fundsmith's universe. Banks are fundamentally incompatible with the Fundsmith quality screen: (1) ROCE/ROCE analysis is meaningless for banks where the balance sheet IS the business and leverage is the operating model, not a distortion; (2) there are no meaningful gross or operating margins to assess pricing power or moats in the traditional sense — NIM is a spread business subject to competitive and regulatory compression; (3) capital intensity is endemic — regulatory capital requirements (CET1 10.5–11%) constrain compounding and force external capital decisions; (4) cash conversion is structurally distorted (FCF-based DCF flagged not applicable by the fact base itself); (5) the business is deeply sensitive to interest rate cycles, credit cycles, and macro conditions — the antithesis of the resilient, predictable, repeat-purchase demand Smith demands. VLY's ROE of 7.66% is well below Smith's 20%+ ROCE threshold, and its asset-light, self-funding growth model requirement is structurally impossible in banking. The fact base itself acknowledges the DCF/FCF framework is not applicable. Stretching my criteria to force a verdict on a regional bank would violate the integrity of the quality lens.

Key points

Banking is explicitly cited by Smith as a capital-intensive, low-return industry incompatible with Fundsmith criteria
ROE of 7.66% is far below the 20%+ ROCE threshold Smith requires
NIM-based revenue model lacks the pricing power, gross margin durability, and moat characteristics Smith screens for
Regulatory capital requirements (CET1 10.5–11%) prevent the asset-light, self-funded compounding Smith prizes
FCF-based valuation framework explicitly flagged as not applicable for banks in the fact base
Interest rate and credit cycle sensitivity is the antithesis of Smith's resilient, predictable demand requirement

Red flags

Bank balance sheet leverage (~12x assets/equity) is a structural disqualifier — debt flatters ROE and adds fragility
Capital intensity is endemic and non-negotiable in regulated banking
No durable gross or operating margins to assess moat quality
Cyclical earnings tied to rate environment and credit cycles
Serial acquisitive history (grew from $20B to $60B via M&A including Leumi acquisition) — Smith distrusts roll-up models

Fact base appendix

Price

last_close: 14.72
as_of: 2026-06-27
high_52w: 14.72
low_52w: 14.72
pct_below_52w_high: 0.0

Fundamentals

last_price: 14.72
market_cap: 7868670000
fifty_two_week_high: 14.94
fifty_two_week_low: 8.77
beta: 1.044407
currency: USD
exchange: NASDAQ NMS - GLOBAL MARKET
sector: Banking
industry: Banking
price_source: finnhub
bars: 1
entity: VALLEY NATIONAL BANCORP
fiscal_year: None
net_income: 597983000
net_income_period: 2025-12-31
operating_cash_flow: 343832000
operating_cash_flow_period: 2025-12-31
capex: 18098000
capex_period: 2025-12-31
total_assets: 64132725000
total_assets_period: 2025-12-31
total_liabilities: 56325027000
total_liabilities_period: 2025-12-31
stockholders_equity: 7807698000
stockholders_equity_period: 2025-12-31
cash_and_equivalents: 428629000
cash_and_equivalents_period: 2018-12-31
long_term_debt: 1654268000
long_term_debt_period: 2018-12-31
shares_outstanding: 555426220
roe: 0.0766
debt_to_equity: 0.2119
current_ratio: None
free_cash_flow: 325734000
pe_ratio: 13.16
price_to_fcf: 24.16
fundamentals_source: edgar_companyfacts
price_to_book: 1.01

Filings reviewed

8-K (2026-05-18) https://www.sec.gov/Archives/edgar/data/714310/000071431026000030/vly-20260518.htm
8-K (2026-05-14) https://www.sec.gov/Archives/edgar/data/714310/000119312526224197/d84505d8k.htm
10-Q (2026-05-07) https://www.sec.gov/Archives/edgar/data/714310/000071431026000027/vly-20260331.htm
10-K (2026-02-27) https://www.sec.gov/Archives/edgar/data/714310/000071431026000017/vly-20251231.htm
10-Q (2025-11-07) https://www.sec.gov/Archives/edgar/data/714310/000071431025000157/vly-20250930.htm
10-K (2025-02-28) https://www.sec.gov/Archives/edgar/data/714310/000071431025000068/vly-20241231.htm

Other sources

[news] How The Valley National Bancorp (VLY) Story Is Shifting With New US$16 Street Targets - Yahoo Finance
[news] Valley National Bancorp's Improving Asset Mix Supports Further Upside (NASDAQ:VLY) - Seeking Alpha
[news] VLY Shares Gain 23.1% So Far in 2026: Should You Buy the Stock Now? - TradingView
[news] Valley National Bancorp (VLY) Stock After 75% One-Year Jump Are Valuation Gaps Closing - simplywall.st
[news] Valley National Bancorp stock hits 52-week high at 14.12 USD - Investing.com
[news] Valley National Bancorp - 8.250% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series C - TradingView
[news] VLY Forecast — Price Target — Prediction for 2027 - TradingView
[news] Valley National Bancorp Q1 2026 Earnings Call Summary - Yahoo Finance
[news] Is Valley National Bancorp (VLY) Pricing Reflecting Recent Share Gains And Earnings Expectations - Yahoo Finance
[news] Price to earnings forward of Valley National Bancorp – FWB:VNB - TradingView
[news] Price to book forward of Valley National Bancorp – NASDAQ:VLY - TradingView
[news] Will Rising Institutional Stakes and Tech-Focused Leadership Accolades Change Valley National Bancorp's (VLY) Narrative? - simplywall.st
[news] Valley National Bancorp Actuals & Estimates (NASDAQ:VLY) - TradingView
[news] Valley National Bancorp (VLY) Stock Could Be 10.5% Undervalued After Stronger Results And Institutional Buying - simplywall.st
[news] Is It Time To Reassess Valley National Bancorp (VLY) After Its Strong 1 Year Rally? - Yahoo Finance
[discussion] $VLY earnings should be better. Salaries are to high.
[discussion] $VLY should be a $20.00 stock ….holding in low price for a while. Go valley
[discussion] $VLY Share Price: $13.38

Contract Selected: Jan 15, 2027 $15 Calls

Buy Zone: $0.55 – $0.68 Target

[discussion] @Shlobby Any you liked?

I got $VLY $BANC $FRST

[discussion] $VLY Outstanding article that hits the mark on VLY's current state. So if you want to refresh yo
[discussion] $VLY $BANC $FRST some regional banks I'm keeping eye on
[discussion] $VLY another regional with ER out of the way
[discussion] [Bullish] $VLY $RKH At the top of my list for eventually getting bought out…IMO!
[discussion] $VLY looks good earnings may head to $15 at that point id look to exit
[discussion] $VLY Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.28 up 55.56% YoY • Reported

[discussion] $VLY strength here
[discussion] $VLY Price: $12.35 (-0.68%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.92% R
[discussion] $KRE $BANC $VLY

Most of these names turned into fakey breakouts. Interested again if they want t

[discussion] $VLY Current Stock Price: $12.53 Contracts to trade: $13.0 VLY Mar 20 2026 Call Entry: $0.10 Exit: $
[discussion] @Knot2 $WAL $BANC $VLY $RF a lot it looks to me
[earnings_call] Valley National Bancorp VLY Q4 2025 Earnings Call

Generated 2026-07-17T21:02:13 · est. cost $1.36

What each investor thinks

AI & Disruption Referee (Christensen-style) Referee

pass · 72

Howard Marks Risk

watch · 55

Ray Dalio Risk

watch · 52

Valuation Referee (Damodaran-style) Referee

watch · 52

Stanley Druckenmiller Risk

watch · 52

Benjamin Graham Value

watch · 52

Peter Lynch Growth

watch · 52

Michael Mauboussin Quality

watch · 52

Warren Buffett Quality

watch · 48

Seth Klarman Value

watch · 48

Walter Schloss Value

watch · 48

Forensic Short-Seller (Chanos/Einhorn-style) Referee

watch · 48

Charlie Munger Quality

watch · 45

Want this on a name you own?Send a ticker; we convene the full council on it.

Request Analysis →